Unit 2.06/31 Lexington Drive, BELLA VISTA , NSW 2153 Ph: 1300 995 098 • www.cambium.bio • ABN 13 127 035 358 ASX Announcement 27 August 2026 Resignation/Appointment of Company Secretary and Communication Person Sydney, Australia; 27 ...
Change in Company Secretary and Communication Person
Filed with ASX · · 1 page · English
Summary by 6ix AI
Cambium Bio Ltd has announced a change in its Company Secretary and Communication Person, effective immediately. Mr. Mark Licciardo has resigned from the position, and Ms. Olga Smejkalova has been appointed as his replacement. The Board expressed gratitude for Mr. Licciardo's service and looks forward to Ms. Smejkalova's contributions. Both Ms. Smejkalova and CEO Mr. Karolis Rosickas will now handle communications with the ASX regarding Listing Rule matters.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Cambium Bio
- Updated Securities Trading Policy
- Quarterly Activities/Appendix 4C Cash Flow Report
- Cambium Bio Raises A$1.0 Million via Placement
- FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
- Half Year Report and Accounts
Later from Cambium Bio
- FY26 Appendix 4G and Corporate Governance Statement
- FY26 Appendix 4E and Annual Report
- Proposed issue of securities - CMB
- Notification regarding unquoted securities - CMB
- Update - Proposed issue of securities - CMB
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio